NYSE · Healthcare
CENTENE CORP (CNC)
As-reported financials and recent SEC filings for CENTENE CORP, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$174.58B
Net income
$-6.67B
Net margin
-3.8%
Diluted EPS
$-13.53
ROE
-33.3%
P/E (TTM)
—
Market cap
$32.19B
Debt / equity
0.9×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $174.58B | $145.50B | $140.09B | $135.48B | $117.98B |
| Gross profit | — | — | — | — | — |
| Operating income | $-7.62B | $3.17B | $2.93B | $1.32B | $1.78B |
| Net income | $-6.67B | $3.31B | $2.70B | $1.20B | $1.35B |
| Diluted EPS | $-13.53 | $6.31 | $4.95 | $2.07 | $2.28 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-02
View on EDGAR →42026-05-26
View on EDGAR →32026-05-18
View on EDGAR →32026-05-18
View on EDGAR →8-K2026-05-15
View on EDGAR →42026-05-13
View on EDGAR →42026-05-13
View on EDGAR →42026-05-13
View on EDGAR →Go deeper on CNC
Search CENTENE CORP’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.